- JP-listed companies
- Income statement
(296A) Income statement
Market cap
¥29.1B
P/E ratio
19.9x
Provides comprehensive accounting consulting and operational support to listed companies, major corporations, and medical institutions, with 83% recurring revenue from ongoing services.
| 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | 2026/03 | |
| Revenue | 371 | 1,290 | 3,066 | 3,885 | 4,423 | 4,979 | 5,705 |
| Revenue growth (%) | - | ||||||
| Cost of revenue | - | - | - | 1,950 | 2,270 | 2,309 | 2,385 |
| Gross profit | - | - | - | 1,935 | 2,154 | 2,671 | 3,320 |
| Gross margin (%) | - | - | - | ||||
| Operating margin (%) | - | - | - | ||||
| Operating expenses | - | - | - | 1,169 | 1,331 | 1,176 | 1,332 |
| Operating income | - | - | - | 765 | 823 | 1,495 | 1,988 |
| Income before tax | 75 | 256 | 381 | 767 | 824 | 1,478 | 1,994 |
| Pretax margin (%) | 20.3 | 19.8 | 12.4 | 19.8 | 18.6 | 29.7 | 35 |
| Provision for income taxes | - | - | - | 139 | 247 | 460 | 556 |
| Effective tax rate (%) | - | - | - | ||||
| Net income | 69 | 171 | 269 | 328 | 577 | 1,018 | 1,415 |
| Earnings per share | 295,458.68 | 2,736.25 | 3,587.98 | 8.72 | 15.33 | 26.96 | 37.81 |
| Dividend per share | - | - | - | - | 11.5 | 24.5 | 32.5 |